Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter
(07 Nov 2025)

Back
Net profit of Bliss GVS Pharma rose 12.32% to Rs 27.25 crore in the quarter ended September 2025 as against Rs 24.26 crore during the previous quarter ended September 2024. Sales rose 12.27% to Rs 244.40 crore in the quarter ended September 2025 as against Rs 217.68 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales244.40217.68 12
OPM %13.0019.05 -
PBDT48.8942.69 15
PBT40.6335.71 14
NP27.2524.26 12

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew